Skip to search formSkip to main contentSkip to account menu

lenampicillin

Known as: (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl(2S,SR,6R)-6-[(R)-2-amino-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3 .2.0]heptane-2-carboxylate hydrochloride 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
The concentrations of ampicillin in serum and mixed saliva after a single oral administration of lenampicillin (500 mg) were… 
1989
1989
A cross-over study was performed comparing serum kinetics and urinary excretion in six healthy, fasting volunteers after… 
1989
1989
A cross-over study was performed comparing serum kinetics and urinary excretion in six healthy, fasting volunteers after… 
1986
1986
The pharmacokinetic properties of lenampicillin (KBT-1585), a new ampicillin ester, were investigated in 41 healthy volunteers… 
1985
1985
Lenampicillin (LAPC) is a novel prodrug of ampicillin (ABPC) which is under development by KANEBO Ltd. and TORII Pharmaceutical… 
1985
1985
Clinical efficacies of newly developed synthetic oral ampicillin prodrug lenampicillin (LAPC, KBT-1585) applied to 109 cases of… 
1985
1985
A double-blind controlled clinical study between lenampicillin (LAPC), a newly developed oral ampicillin (ABPC) prodrug, and… 
1985
1985
A comparative double blind study of lenampicillin (LAPC, KBT-1585) and talampicillin (TAPC) was carried out in order to…